Literature DB >> 19322680

Prostatic acid phosphatase, a neglected ectonucleotidase.

Herbert Zimmermann1.   

Abstract

Two recent papers reveal that the soluble and secreted prostatic acid phosphatase, an enzyme that has long served as a diagnostic marker for prostate cancer, has a membrane-bound splice variant. This enzyme exhibits ecto-5'-nucleotidase activity, is widely distributed, and implicated in the formation of chronic pain. While prostatic acid phosphatase hydrolyzes phosphomonoesters other than 5'-nucleoside monophosphates these novel data suggest that, in addition to ecto-5'-nucleotidase and the alkaline phosphatases, prostatic acid phosphatase must be taken into account in future studies on extracellular adenosine production.

Entities:  

Year:  2009        PMID: 19322680      PMCID: PMC2717315          DOI: 10.1007/s11302-009-9157-z

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  19 in total

Review 1.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

2.  Distribution of ectonucleotidases in the rodent brain revisited.

Authors:  David Langer; Klaus Hammer; Patrycja Koszalka; Jürgen Schrader; Simon Robson; Herbert Zimmermann
Journal:  Cell Tissue Res       Date:  2008-10-09       Impact factor: 5.249

3.  Phosphatases in the substantia gelatinosa and motoneurones: a comparative histochemical study.

Authors:  S Sanyal; A Rustioni
Journal:  Brain Res       Date:  1974-08-09       Impact factor: 3.252

Review 4.  Recent findings on ultracytochemistry of thiamin phosphatases.

Authors:  K Ogawa; M Sakai; K Inomata
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

5.  Human prostatic acid phosphatase: a histidine phosphatase.

Authors:  R L Van Etten
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  Human tartrate-resistant acid phosphatase becomes an effective ATPase upon proteolytic activation.

Authors:  Natasa Mitić; Mohsen Valizadeh; Eleanor W W Leung; John de Jersey; Susan Hamilton; David A Hume; A Ian Cassady; Gerhard Schenk
Journal:  Arch Biochem Biophys       Date:  2005-07-15       Impact factor: 4.013

Review 7.  Lysophosphatidic acid and autotaxin: emerging roles in innate and adaptive immunity.

Authors:  Steve N Georas
Journal:  Immunol Res       Date:  2009-01-30       Impact factor: 2.829

Review 8.  Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy.

Authors:  Alison R Hayman
Journal:  Autoimmunity       Date:  2008-04       Impact factor: 2.815

Review 9.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

Review 10.  Acid phosphatase as a selective marker for a class of small sensory ganglion cells in several mammals: spinal cord distribution, histochemical properties, and relation to fluoride-resistant acid phosphatase (FRAP) of rodents.

Authors:  J D Silverman; L Kruger
Journal:  Somatosens Res       Date:  1988
View more
  17 in total

Review 1.  Pain-relieving prospects for adenosine receptors and ectonucleotidases.

Authors:  Mark J Zylka
Journal:  Trends Mol Med       Date:  2011-01-13       Impact factor: 11.951

2.  Why do male mice spit soluble enzymes that hydrolyze extracellular nucleotides? Focus on "Prostatic acid phosphatase is the main acid phosphatase with 5'-ectonucleotidase activity in the male mouse saliva and regulates salivation".

Authors:  Gary A Weisman
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-09       Impact factor: 4.249

3.  Screening and characterization of a novel RNA aptamer that specifically binds to human prostatic acid phosphatase and human prostate cancer cells.

Authors:  Hoon Young Kong; Jonghoe Byun
Journal:  Mol Cells       Date:  2015-01-15       Impact factor: 5.034

Review 4.  Targeting immunosuppressive adenosine in cancer.

Authors:  Dipti Vijayan; Arabella Young; Michele W L Teng; Mark J Smyth
Journal:  Nat Rev Cancer       Date:  2017-10-23       Impact factor: 60.716

5.  High-throughput screen identifies cyclic nucleotide analogs that inhibit prostatic acid phosphatase.

Authors:  Eric S McCoy; Wendy A Lea; Bryan T Mott; David J Maloney; Ajit Jadhav; Anton Simeonov; Mark J Zylka
Journal:  J Biomol Screen       Date:  2012-11-27

Review 6.  Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches.

Authors:  Elizabeth A Thompson; Jonathan D Powell
Journal:  Annu Rev Med       Date:  2020-09-09       Impact factor: 13.739

Review 7.  In Search of a Role for Extracellular Purine Enzymes in Bone Function.

Authors:  Mariachiara Zuccarini; Patricia Giuliani; Francesco Caciagli; Renata Ciccarelli; Patrizia Di Iorio
Journal:  Biomolecules       Date:  2021-04-30

Review 8.  Purines as potential morphogens during embryonic development.

Authors:  Karine Massé; Nicholas Dale
Journal:  Purinergic Signal       Date:  2012-01-25       Impact factor: 3.765

Review 9.  Emerging roles of human prostatic Acid phosphatase.

Authors:  Hoon Young Kong; Jonghoe Byun
Journal:  Biomol Ther (Seoul)       Date:  2013-01       Impact factor: 4.634

Review 10.  Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantation.

Authors:  Petya Chernogorova; Robert Zeiser
Journal:  J Biomed Biotechnol       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.